Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong

We conducted a territorywide survey to investigate the epidemiology, risk factors, and clinical outcomes of Clostridioides difficile infection (CDI) among hospitalized patients in Hong Kong. A total of 17,105 cases of CDI were identified, of which 15,717 (91.9%) were healthcare-associated and 1,025...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cosmos L.T. Guo, Thomas N.Y. Kwong, Joyce W.Y. Mak, Lin Zhang, Grace C.Y. Lui, Grace L.H. Wong, Margaret Ip, Jun Yu, Joseph J.Y. Sung, William K.K. Wu, Sunny H. Wong
Formato: article
Lenguaje:EN
Publicado: Centers for Disease Control and Prevention 2021
Materias:
R
Acceso en línea:https://doaj.org/article/7b3b80364d4f489c88ddb93f61ac8ab3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7b3b80364d4f489c88ddb93f61ac8ab3
record_format dspace
spelling oai:doaj.org-article:7b3b80364d4f489c88ddb93f61ac8ab32021-11-22T12:56:56ZTrends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong10.3201/eid2712.2037691080-60401080-6059https://doaj.org/article/7b3b80364d4f489c88ddb93f61ac8ab32021-12-01T00:00:00Zhttps://wwwnc.cdc.gov/eid/article/27/12/20-3769_articlehttps://doaj.org/toc/1080-6040https://doaj.org/toc/1080-6059 We conducted a territorywide survey to investigate the epidemiology, risk factors, and clinical outcomes of Clostridioides difficile infection (CDI) among hospitalized patients in Hong Kong. A total of 17,105 cases of CDI were identified, of which 15,717 (91.9%) were healthcare-associated and 1,025 (6.0%) were community-associated. Although CDI incidence increased substantially from 2006 to 2017, it plateaued in 2018 and 2019. The 30-day mortality rates decreased from 20.1% in 2015 to 16.8% in 2019, whereas the 60-day recurrence rates remained constant at ≈11% during the study period. Cross-correlation statistic showed significant correlations between incidence trend and overall antimicrobial drug use (r = 0.865, p<0.001), which has decreased as a result of an antibiotic stewardship program initiated in 2017. Our data suggest a turning point in C. difficile epidemiology that could be related to the changing pattern of antimicrobial drug use. Cosmos L.T. GuoThomas N.Y. KwongJoyce W.Y. MakLin ZhangGrace C.Y. LuiGrace L.H. WongMargaret IpJun YuJoseph J.Y. SungWilliam K.K. WuSunny H. WongCenters for Disease Control and PreventionarticleClostridioides difficilepseudomembranous colitisantimicrobial resistanceepidemiologysurveillanceHong KongMedicineRInfectious and parasitic diseasesRC109-216ENEmerging Infectious Diseases, Vol 27, Iss 12, Pp 3036-3044 (2021)
institution DOAJ
collection DOAJ
language EN
topic Clostridioides difficile
pseudomembranous colitis
antimicrobial resistance
epidemiology
surveillance
Hong Kong
Medicine
R
Infectious and parasitic diseases
RC109-216
spellingShingle Clostridioides difficile
pseudomembranous colitis
antimicrobial resistance
epidemiology
surveillance
Hong Kong
Medicine
R
Infectious and parasitic diseases
RC109-216
Cosmos L.T. Guo
Thomas N.Y. Kwong
Joyce W.Y. Mak
Lin Zhang
Grace C.Y. Lui
Grace L.H. Wong
Margaret Ip
Jun Yu
Joseph J.Y. Sung
William K.K. Wu
Sunny H. Wong
Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong
description We conducted a territorywide survey to investigate the epidemiology, risk factors, and clinical outcomes of Clostridioides difficile infection (CDI) among hospitalized patients in Hong Kong. A total of 17,105 cases of CDI were identified, of which 15,717 (91.9%) were healthcare-associated and 1,025 (6.0%) were community-associated. Although CDI incidence increased substantially from 2006 to 2017, it plateaued in 2018 and 2019. The 30-day mortality rates decreased from 20.1% in 2015 to 16.8% in 2019, whereas the 60-day recurrence rates remained constant at ≈11% during the study period. Cross-correlation statistic showed significant correlations between incidence trend and overall antimicrobial drug use (r = 0.865, p<0.001), which has decreased as a result of an antibiotic stewardship program initiated in 2017. Our data suggest a turning point in C. difficile epidemiology that could be related to the changing pattern of antimicrobial drug use.
format article
author Cosmos L.T. Guo
Thomas N.Y. Kwong
Joyce W.Y. Mak
Lin Zhang
Grace C.Y. Lui
Grace L.H. Wong
Margaret Ip
Jun Yu
Joseph J.Y. Sung
William K.K. Wu
Sunny H. Wong
author_facet Cosmos L.T. Guo
Thomas N.Y. Kwong
Joyce W.Y. Mak
Lin Zhang
Grace C.Y. Lui
Grace L.H. Wong
Margaret Ip
Jun Yu
Joseph J.Y. Sung
William K.K. Wu
Sunny H. Wong
author_sort Cosmos L.T. Guo
title Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong
title_short Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong
title_full Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong
title_fullStr Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong
title_full_unstemmed Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong
title_sort trends in incidence and clinical outcomes of clostridioides difficile infection, hong kong
publisher Centers for Disease Control and Prevention
publishDate 2021
url https://doaj.org/article/7b3b80364d4f489c88ddb93f61ac8ab3
work_keys_str_mv AT cosmosltguo trendsinincidenceandclinicaloutcomesofclostridioidesdifficileinfectionhongkong
AT thomasnykwong trendsinincidenceandclinicaloutcomesofclostridioidesdifficileinfectionhongkong
AT joycewymak trendsinincidenceandclinicaloutcomesofclostridioidesdifficileinfectionhongkong
AT linzhang trendsinincidenceandclinicaloutcomesofclostridioidesdifficileinfectionhongkong
AT gracecylui trendsinincidenceandclinicaloutcomesofclostridioidesdifficileinfectionhongkong
AT gracelhwong trendsinincidenceandclinicaloutcomesofclostridioidesdifficileinfectionhongkong
AT margaretip trendsinincidenceandclinicaloutcomesofclostridioidesdifficileinfectionhongkong
AT junyu trendsinincidenceandclinicaloutcomesofclostridioidesdifficileinfectionhongkong
AT josephjysung trendsinincidenceandclinicaloutcomesofclostridioidesdifficileinfectionhongkong
AT williamkkwu trendsinincidenceandclinicaloutcomesofclostridioidesdifficileinfectionhongkong
AT sunnyhwong trendsinincidenceandclinicaloutcomesofclostridioidesdifficileinfectionhongkong
_version_ 1718417559947051008